Intrinsic Value of S&P & Nasdaq Contact Us

iMD Companies, Inc. ICBU OTC

Other OTC • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
9/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

iMD Companies, Inc. (ICBU) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 9/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
9/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
22/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ICBU

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.69
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $0.00 $984.00 $-833.71K -84726.6%
2016 $0.00 $8.15M $292.56K 3.6%
2017 $0.00 $18.62M $-17.97K -0.1%
2018 $0.00 $1.84M $-464.93K -25.2%
2019 $0.00 $0.00 $-39.72K -
2020 $0.00 $0.00 $-72.59K -
2021 $0.00 $28.65K $-157.23K -548.8%
2022 $0.00 $8.38K $-314.7K -3757.6%
2023 $0.00 $0.00 $-200.64K -
2024 $0.00 $1.02M $-1.25M -123%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message